Navigation Links
Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
Date:12/3/2007

lity of this novel compound as a new therapeutic option for patients affected by hypertension and related disorders such as diabetic nephropathy," stated Rene Belder, M.D., Pharmacopeia's Vice President of Clinical and Regulatory Affairs. "We look forward to the completion of our ongoing Phase 2a study in the first half of 2008 and hope to see the first clear demonstration of the compound's potential efficacy in hypertensive patients."

PS433540 is a dual-acting angiotensin (AII) and endothelin (ET1) receptor antagonist that is being developed as a potential treatment for hypertension and diabetic nephropathy. PS433540, the first and only DARA compound in development, possesses two clinically validated mechanisms of action in a single compound. There is considerable preclinical and initial clinical data suggesting that compared to either agent alone, simultaneously blocking the actions of both AII and ET1 may provide significantly improved treatment options for several cardiovascular diseases.

ABOUT PHARMACOPEIA

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including seven clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic agreements with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Cephalon, GlaxoSmithKline, Organon, Schering-Plough, and Wyeth Pharmaceuticals. For more information please visit the company's website at h
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
4. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
5. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015  The inaugural ... the use of health technology innovations that improve ... foster collaborations to improve development and adoption of ... the structures and processes within delivery systems that ... providers, investors, entrepreneurs, developers and other stakeholders, takes ...
(Date:3/26/2015)... , March 26, 2015 ... "Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse ... On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, ... by MarketsandMarkets, the Pharmacovigilance and Drug Safety Software ... of 6.5% during 2014-2019, and is expected to ...
(Date:3/26/2015)... -- Flexpoint Sensor Systems, Inc. (OTCBB: FLXT) today announced several ... shipped during the last 90 days. Flexpoint ... sensors for gloves and medical uses. Several new customers ... built for them. Some of these new clients include ... rehab; a major international electronics manufacturer who is using ...
Breaking Medicine Technology:HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 2HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 3HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 2015 The American College of Traditional Chinese ... topics of the DAOM Program as well as Marketing Basics ... will be hosted by Dr. Carla Wilson, who will give ... on how to prepare for the spring quarter. The webinar ... 27, April 1 and April 3. Attendees can log in ...
(Date:3/26/2015)... MALVERN, PA (PRWEB) March 26, 2015 ... leading providers of continuing medical education, the ... for Culinary Medicine at Tulane University are ... in Culinary Medicine. The interdisciplinary program ... Specialist (CCMS) credential, is designed for physicians, nurse ...
(Date:3/26/2015)... U.S. medical real estate sales transactions ... to an exclusive new report now available only ... (HRE) data firm also announced that it has ... Partners: Harrison Street Real Estate Capital and Zeustra ... going strong, yields compressed, prices per square foot ...
(Date:3/26/2015)... 2015 BioPlus Specialty Pharmacy ... specialty pharmacies, announces the promotion of Sharon Ferrer ... of Pharmaceutical Relations. In this position, Ferrer will ... pharmaceuticals partners and providing key leadership in building ... expansion. , “Over the past seven years ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... 29 (HealthDay News) -- Not turning the clocks back an ... improve people,s health and well-being, according to an English expert. ... of "accessible" daylight hours during the fall and winter and ... senior fellow emeritus at the Policy Studies Institute in London. ...
... 29 (HealthDay News) -- More than half of the ... want to have full control over life-support choices and ... a new study. It included 230 surrogate decision ... who had about a 50 percent chance of dying ...
... THURSDAY, Oct. 28 (HealthDay News) -- Elderly kidney failure patients in ... transplant as they were in the mid-1990s, although the likelihood is ... in the United States have kidney failure, and 48 percent of ... upcoming issue of the Clinical Journal of the American Society ...
... Weill Cornell Medical College have identified a potential new treatment ... viruses for which there is currently no treatment or vaccine ... measles, mumps and the flu. The new research appears in ... Science (PLoS) Pathogens . The Nipah and Hendra viruses are ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Oct. 28 ... pre-cancerous polyps and colon tumors appears to be more accurate ... test, Mayo clinic researchers say. The search for a highly ... sigmoidoscopy is a "Holy Grail" of colon cancer research. ...
... long life, but may do so at the expense of ... 11-year study of a population of wild sheep located on ... the animals, susceptibility to infection may give new insight into ... the same illness. The answer to this medical puzzle ...
Cached Medicine News:Health News:Is It Time to Ditch the Daylight Saving Time Switch? 2Health News:Most Health Proxies Would Make End-of-Life Decisions Themselves: Study 2Health News:Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers 2Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 2Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 3Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 4Health News:Wild Scottish sheep could help explain differences in immunity 2Health News:Wild Scottish sheep could help explain differences in immunity 3
... STAT analyzer and data management ... to meet the traditional needs of data ... functions for the management of STAT analyzer ... and simple connectivity solution for both STAT ...
... syngo Dynamics network is a ... archiving system using evidence-based reporting ... clinical procedures. It has made ... reality for hospital echocardiography and ...
... dTC is a versatile solution designed to ... from preparation to diagnosis and therapy, ... AXIOM Artis dTC, your cath lab becomes ... that leaves you free to concentrate on ...
... cardiovascular system PLUS ... high-performance transesophageal cardiovascular imaging system ... phased array echocardiography system that ... images, even on your most ...
Medicine Products: